Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in

Liu-Ya Tang1, Mary Heller1, Zhaojing Meng2

  • 1From the Laboratory of Cellular and Molecular Biology, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland 20892 and.

Insights

Transforming growth factor-β (TGF-β) activates STATs through a SMAD-independent JAK1 pathway within minutes. A second SMAD-dependent phase requires protein synthesis, with JAK1/STAT3 and SMADs cooperating in liver fibrosis.

Area of Science:

  • Cellular biology
  • Molecular signaling
  • Hepatology

Background:

  • Transforming growth factor-β (TGF-β) mediates diverse biological effects via SMAD and non-SMAD pathways.
  • STATs and SMADs coordinate TGF-β functions in hepatic cells, but STAT activation mechanisms remain unclear.

Purpose of the Study:

  • To elucidate the mechanism of STAT activation by TGF-β in hepatic cells.
  • To investigate the role of JAK1 and SMADs in TGF-β-induced STAT phosphorylation.
  • To determine the contribution of the JAK1/STAT pathway to TGF-β target gene expression and liver fibrosis.

Main Methods:

  • Investigated JAK1 as a TGFβRI binding protein.
  • Assessed STAT phosphorylation in a SMAD-independent manner following TGF-β stimulation.
  • Analyzed a second phase of STAT phosphorylation requiring SMADs and de novo protein synthesis.
  • Utilized global gene expression profiling in hepatic stellate cells.

Main Results:

  • JAK1 is constitutively bound to TGFβRI and essential for rapid, SMAD-independent STAT phosphorylation upon TGF-β stimulation.
  • A secondary phase of STAT phosphorylation occurs later, dependent on SMADs and de novo protein synthesis, with JAK1 involvement.
  • The non-SMAD JAK1/STAT pathway is crucial for a subset of TGF-β target genes in hepatic stellate cells.
  • Cooperation between JAK1-STAT3 and SMAD pathways is vital for TGF-β's role in liver fibrosis.

Conclusions:

  • JAK1 mediates an early, SMAD-independent STAT activation by TGF-β.
  • A later, SMAD-dependent STAT activation phase also involves JAK1 and protein synthesis.
  • The JAK1/STAT3 and SMAD pathways cooperate to drive TGF-β-induced liver fibrosis.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K